Nicola di Rienzo

12PUBLICATIONS
85CO-AUTHORS
NanomedicineCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical virologyIndustrial biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 17, 2026
Real-world outcomes of venetoclax plus hypomethylating agents in unfit acute myeloid leukaemia: Results of the GIMEMA AML2320 trial.

|Jun 29, 2025
Chronic myeloid leukemia outcomes according to baseline risk and first-line treatment in real-world settings: Data from the Italian Network/CML Campus.

Valentina Giai, Tiziana Rosso, Fausto Castagnetti

|Mar 22, 2025
INO-CD22: A multicenter, real-world study of inotuzumab ozogamicin safety and effectiveness in adult patients with relapsed/refractory acute lymphoblastic leukemia.

Cristina Papayannidis, Elisabetta Petracci, Patrizia Zappasodi

|Mar 20, 2025
Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real-world setting: Interim results of the Italian observational study (ROMEI).

Massimo Breccia, Francesca Palandri, Maurizio Martelli

|Jan 23, 2024
Serological and Molecular Characterization of Occult HBV Infection in Blood Donors from South Italy.

Alessia Sticchi Damiani, Vera Holzmayer, Claudio Galli

|Jul 13, 2023
Association between ABO blood groups and SARS-CoV-2 infection in blood donors of Puglia region.

Alessia Sticchi Damiani, Antonella Zizza, Federico Banchelli

Pageof 2

Frequent Collaborators

3 joint publications

Massimo Breccia

3 joint publications

Erika Borlenghi

2 joint publications

Adriano Venditti

2 joint publications

Cristina Papayannidis